You are here
CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse
About this Study
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of CMA-676 in treating older patients who
have acute myeloid leukemia that has recurred for the first time following at least 3 months
of complete remission.